SDA

Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer

Product code
SDA
Device name
Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer
Device class
Class 3
Medical specialty
Unknown
Marketing pathway
PMA
Flag
Life-sustaining / life-supporting

FDA classification definition

Optune Lua concurrent with PD-1/PD-L1 inhibitors or docetaxel is indicated for adult patients with metastatic non-small cell lung cancer who have progressed on or after a platinum-based regimen.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: SDA
Classification and pathway per current FDA publications. Data from openFDA (CC0).